BioSpace News Archive

BioMidwest

MIM Software Becomes Majority Vendor for RPT in Centers of Excellence

MIM Software Inc., a leading global provider of medical imaging software, is bringing its personalized dosimetry application to a growing majority of healthcare centers, providing clinicians and patients with advanced treatment insights.

March 29, 2023
·
2 min read
Deals

Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board

Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the completion of its acquisition of selected assets from Otonomy, Inc.

March 29, 2023
·
4 min read
Drug Development

Gain Therapeutics to Present Positive Preclinical Data on its GBA1 Program at the AD/PD 2023 Meeting

Gain Therapeutics, Inc. today announced the presentation of new pre-clinical data supporting the potential of its structurally targeted allosteric regulators (STARs) of glucocerebrosidase (GCase) to prevent neurodegeneration in Alzheimer’s disease (AD).

March 29, 2023
·
6 min read
Pharm Country

Celldex Therapeutics to Present at H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 30th at 11:30 am ET.

March 29, 2023
·
1 min read
BioCapital

FDA Approves First Over-the-Counter Naloxone Nasal Spray

Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription.

March 29, 2023
·
5 min read
Pharm Country

Applied DNA Achieves Milestone for Large-Scale linearDNA™ Production, Delivers Largest Single Shipment by Volume to Date

Applied DNA Sciences, Inc. today announced that it has established a new high bar for the production of DNA with the manufacture and shipment of a multi-gram quantity of linearDNA™ in under six weeks.

March 29, 2023
·
4 min read
Bio NC

Compass Group and AstraZeneca Expand Activities Focused on Innovation and Shared Success

Continuing a shared commitment to innovation, Compass Group, the world’s largest food and facility services company, and AstraZeneca, the global, science-led, patient-focused pharmaceutical company, are taking supplier management to the next level.

March 29, 2023
·
3 min read
Business

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update

Milestone Pharmaceuticals Inc. today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a clinical and corporate update.

March 29, 2023
·
14 min read
Deals

Coeptis Therapeutics Secures Exclusive Rights to Negotiate to Acquire Transformational Cell Therapy Platform to Enable Potent Combinatorial Immuno-Oncology Treatment Strategies

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, announced it has obtained the exclusive right to negotiate towards the acquisition of VyGen-Bio, Inc. or its assets.

March 29, 2023
·
8 min read
Sona Nanotech Grants Options - March 2023

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF), (the “Company”) is pleased to announce that it has granted 1,225,000 incentive stock options under the Company’s Stock Option Plan (“Option Plan”) of which 1,175,000 have been granted to a Directors and Officers.

March 29, 2023
·
2 min read